MedTrace Logo

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

NCT04002986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2023-07-24

No results posted yet for this study

Summary

Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist providers in improving screening and preventative options.

Conditions

  • Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8

Interventions

GENETIC

Genetic Testing

A blood draw or saliva kit will be provided to collect subject cells

Sponsors & Collaborators

Principal Investigators

  • N. Jewel Samadder, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-20
Primary Completion
2021-05-24
Completion
2021-05-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04002986 on ClinicalTrials.gov